Skip to main content
OpenTrials
Completed

NCT Number: NCT05772078

Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis

Peri-implantitis is a plaque-mediated inflammatory condition featured by progressive bone loss. This entity jeopardizes the longevity of dental implants, thus impacting negatively on the quality of life of patients. Moreover, peri-implantitis is suggested to lead to an increased systemic status of inflammation. This may rise the susceptibility to experience life-threating conditions. Therefore, peri-implant infections must be promptly diagnosed and eliminated.

Aiming at resolving the inflammation, several options are advised to remove the infection. Accordingly, implant removal or therapeutic manoeuvres to stablish a healthy ecosystem in the peri-implant environment have been suggested. While the former proved being more predictable, the later demonstrated being more conservative. Indeed, implant removal is commonly associated with regenerative procedures of the alveolar bone deformity that often demand time and is more costly. Anyways, disease severity, implant expendability for biomechanical reasons or esthetic demand seem to be few of the leading aspects in the decision-making process on maintaining or extracting implant showing peri-implant lesions.

Supportive maintenance care (SPT) was shown to be key in preventing disease recurrence. Nonetheless, the compliance of these patients is often erratic. In fact, it is yet unknown the rate of compliance after therapy. Therefore, the goal of this study is to assess the rate and confounders for compliance.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro de Implantologia Cirugia Oral y Maxilofacial

Badajoz, 06011, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients that underwent treatment of peri-implantitis
  • >12 months of follow-up after therapy
  • Patients managed in our center

Exclusion criteria

  • Patients that were managed in other centers
  • Patients that have incomplete records

Treatment and study plan

Assess compliance rate and demographics

Other

Records to evaluate attendance rate

Primary outcomes

  1. Compliance rate

    Time frame: 1 to 6 years of follow-up

    How many patients are complete compliers

Secondary outcomes

  1. Demographics

    Time frame: 1 to 6 years of follow-up

    Evaluate the patient-related features affecting compliance

Other outcomes

  1. Cumulative Interceptive Rate

    Time frame: 1 to 6 years of follow-upo

    Interventions needed after active therapy to manage peri-implantitis during supportive peri-implant care for erratic and regular compliers

Sponsors and collaborators

Lead sponsor

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

Other

Registry information

Official study title

Compliance Rate After Therapy of Peri-implantitis: Retrospective Study

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Mar 16, 2023
Registry last updated
Apr 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.